FDA approves new treatment for rare form of hemophilia

The U.S. Food and Drug Administration yesterday approved Obizur [Antihemophilic Factor (Recombinant), Porcine Sequence] for the treatment of bleeding episodes in adults with acquired hemophilia A (acquired Factor VIII [FVII] deficiency).

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm420263.htm

Source: Food and Drug Administration - October 24, 2014 Category: American Health Source Type: news

More News: American Health | Bleeding | Food and Drug Administration (FDA) | Haemophilia | Hemophilia